Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 2, 2020Journal of Clinical InvestigationOpen Access

High residual C-peptide likely contributes to glycemic control in type 1 diabetes

View Full Paper
Ask AI
Bookmark
Share

Authors

MRMichael R. RickelsBryn Mawr CollegeCECarmella Evans‐MolinaRichard L. Roudebush VA Medical CenterHBHenry T. BahnsonKing's College London

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Rickels et al. (2020) studied this question.

synapsesocial.com/papers/6a707443e71d69abee089fd7https://doi.org/10.1172/jci134057
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Correlation Between Minimal Secretory Capacity of Pancreatic β-Cells and Stability of Diabetic Control1988 · 147 citations
  2. 2Hypoglycemia in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group1997 · 448 citations
  3. 3Effects of Age, Duration and Treatment of Insulin-Dependent Diabetes Mellitus on Residual β -Cell Function: Observations During Eligibility Testing for the Diabetes Control and Complications Trial (DCCT)1987 · 222 citations
  4. 4Impact of C-Peptide Preservation on Metabolic and Clinical Outcomes in the Diabetes Control and Complications Trial2013 · 288 citations
  5. 5Reduced β-Cell Secretory Capacity in Pancreatic-Insufficient, but Not Pancreatic-Sufficient, Cystic Fibrosis Despite Normal Glucose Tolerance2016 · 85 citations